1620 INVESTMENT ADVISORS, INC.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1907281
PLYMOUTH, MA
Position in ALNY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$36,725
New position
Shares Held
122
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#634
of 780 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 50%
Shared 0%
None 50%
Position in Biotechnology
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $527,185 across 9 Biotechnology names. ALNY ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
3,735 | $205,200 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
1,721 | $108,319 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
187 | $92,888 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
122 | $36,725 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
1,300 | $21,996 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
711 | $18,642 | |
| 7 | SVRA |
Savara Inc
|
3,000 | $18,480 | |
| 8 | PHVS |
Pharvaris N.V.
|
520 | $17,981 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,725 | 122 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||